Clinical Trial
doi: 10.1007/BF02247375.
Attenuation of some alcohol-induced mood changes and the desire to drink by 5-HT3 receptor blockade: a preliminary study in healthy male volunteers
Affiliations
- PMID: 7871004
- DOI: 10.1007/BF02247375
Item in Clipboard
Clinical Trial
Attenuation of some alcohol-induced mood changes and the desire to drink by 5-HT3 receptor blockade: a preliminary study in healthy male volunteers
Psychopharmacology (Berl).
1993.
Abstract
We studied the effect of the 5-HT3 receptor antagonist ondansetron (4 mg orally) on some of the psychological effects of a small dose of alcohol (580 ml of 3.6% alcohol content by volume of lager) in 16 healthy male volunteers using a double-blind placebo controlled, Latin Square cross-over design. Pretreatment with ondansetron significantly attenuated several of the subjective pleasurable effects of alcohol, and also decreased the subjective desire to drink. These findings are consistent with preclinical studies suggesting that the reinforcing properties of alcohol may be attenuated by 5-HT3 receptor blockade.
Similar articles
-
Ondansetron alters human alcohol intoxication.Biol Psychiatry. 1996 Sep 15;40(6):514-21. doi: 10.1016/0006-3223(95)00432-7. Biol Psychiatry. 1996. PMID: 8879472 Clinical Trial.
-
Ondansetron, a 5-HT3 receptor antagonist, partially attenuates the effects of amphetamine: a pilot study in healthy volunteers.Int Clin Psychopharmacol. 1992 Spring;7(1):37-43. doi: 10.1097/00004850-199200710-00005. Int Clin Psychopharmacol. 1992. PMID: 1385603 Clinical Trial.
-
Biological and behavioral responses to D-amphetamine, alone and in combination with the serotonin3 receptor antagonist ondansetron, in healthy volunteers.Psychiatry Res. 1996 Aug 30;64(1):1-10. doi: 10.1016/0165-1781(96)02884-3. Psychiatry Res. 1996. PMID: 8888359 Clinical Trial.
-
Pharmacology and preclinical antiemetic properties of ondansetron.Semin Oncol. 1992 Aug;19(4 Suppl 10):1-8. Semin Oncol. 1992. PMID: 1387245 Review.
-
Exploring psychological benefits associated with moderate alcohol use: a necessary corrective to assessments of drinking outcomes?Drug Alcohol Depend. 2000 Nov 1;60(3):221-47. doi: 10.1016/s0376-8716(00)00112-5. Drug Alcohol Depend. 2000. PMID: 11053757 Review.
Cited by
-
Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review.Front Pharmacol. 2022 Oct 3;13:927703. doi: 10.3389/fphar.2022.927703. eCollection 2022. Front Pharmacol. 2022. PMID: 36263121 Free PMC article. Review.
-
Acute effects of memantine in combination with alcohol in moderate drinkers.Psychopharmacology (Berl). 2004 Feb;172(1):16-24. doi: 10.1007/s00213-003-1617-5. Epub 2003 Oct 3. Psychopharmacology (Berl). 2004. PMID: 14530901 Clinical Trial.
-
A Review of the Characteristics of Clinical Trials and Potential Medications for Alcohol Dependence: Data Analysis from ClinicalTrials.gov.Medicina (Kaunas). 2023 Jun 7;59(6):1101. doi: 10.3390/medicina59061101. Medicina (Kaunas). 2023. PMID: 37374305 Free PMC article. Review.
-
Mutations of L293 in transmembrane two of the mouse 5-hydroxytryptamine3A receptor alter gating and alcohol modulatory actions.Br J Pharmacol. 2006 May;148(1):88-101. doi: 10.1038/sj.bjp.0706685. Br J Pharmacol. 2006. PMID: 16520747 Free PMC article.
-
Alcohols potentiate the function of 5-HT3 receptor-channels on NCB-20 neuroblastoma cells by favouring and stabilizing the open channel state.J Physiol. 1998 Mar 1;507 ( Pt 2)(Pt 2):335-52. doi: 10.1111/j.1469-7793.1998.335bt.x. J Physiol. 1998. PMID: 9518697 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
